David Mehalick
@davidmehalick4071
CEO
Building Coeptis Pharmaceuticals, Inc. as CEO
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Coeptis Pharmaceuticals, Inc. was founded in 2018 and has no closure on record.
Named alongside
At Coeptis Pharmaceuticals, Inc.
- Christine SheehyExecutive Officer, Director
- Dan YeraceVice-President
At Coeptis Therapeutics Holdings, Inc.
- Brian CogleyExecutive Officer
- Christine SheehyExecutive Officer
- Christopher CaliseDirector
- Christopher CochranDirector
- Christopher Maria CochranDirector
- Colleen DelaneyExecutive Officer
- Daniel YeraceExecutive Officer, Director
- Gene Maria SalkindDirector
- Brian CogleyExecutive Officer, Director
- Bruce CassidyDirector
- Martin LewisDirector
- Michael LewisPromoter
- Robert LewisExecutive Officer, Director, Promoter
- Tamara JovonovichExecutive Officer, Director, Promoter
- Brian CogleyExecutive Officer, Director
- Bruce CassidyDirector
- Martin LewisDirector
- Michael LewisPromoter
- Robert LewisExecutive Officer, Director, Promoter
- Christine SheehyExecutive Officer, Director
- Daniel YeraceExecutive Officer, Director
- Michael HandleyDirector
Contribution
David's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Coeptis Pharmaceuticals, Inc.CEO · Pharmaceuticals · WEXFORD, United States · Founded 2018
- VININGS HOLDINGS, INC.Pharmaceutical Preparations; formerly VININGS HOLDINGS, INC.; filing with the SEC since 2020Executive Officer, Director · Pharmaceuticals · WEXFORD, United States
- Coeptis Therapeutics Holdings, Inc.Finance Services; formerly Coeptis Therapeutics Holdings, Inc.; listed on Nasdaq as ZSQR; filing with the SEC since 2019Executive Officer, Director · Pharmaceuticals · WEXFORD, United States · Founded 2022
- Jabez Biosciences, Inc.Pharmaceutical Preparations; filing with the SEC since 2024Promoter · Biotechnology · CRANBERRY TWP., United States · Founded 2024
- Nok Therapeutics, Inc.Pharmaceutical Preparations; listed on OTC as NKTPD; filing with the SEC since 2024Promoter · Biotechnology · CRANBERRY TWP., United States · Founded 2024